Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Epizyme Inc (NQ: EPZM )

9.590 USD -0.070 (-0.72%)
Official Closing Price Updated: 5:56 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,159,500
Open 9.720
Bid (Size) 9.550 (1)
Ask (Size) 9.720 (1)
Prev. Close 9.660
Today's Range 9.420 - 9.860
52wk Range 9.420 - 23.61
Shares Outstanding 69,487,808
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Epizyme to Host Strategic Vision Call on March 2, 2021
Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that it will host a call to discuss the... 
From Business Wire News Releases
CORRECTING and REPLACING Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Third subhead of release should read: Safety Run-In Portion of Confirmatory Trials of TAZVERIK® in ES and FL and Phase 1b Portion of Phase 1b/2 Castration-Resistant Prostate Cancer Fully Enrolled;... 
From Business Wire News Releases

Performance

YTD
-10.46%
-10.46%
1 Month
-15.66%
-15.66%
3 Month
-30.20%
-30.20%
6 Month
-26.23%
-26.23%
1 Year
-55.25%
-55.25%

More News

Read More
Epizyme Announces Date of Fourth Quarter and Full Year 2020 Financial Results and Participation in Upcoming Investor Conferences
From Business Wire News Releases
Stocks That Hit 52-Week Lows On Thursday
Tags News BZI/52Weeks Trading Ideas
From Benzinga
Epizyme: Q4 Earnings Insights
Tags News Market News EPZM
From Benzinga
Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development
From Business Wire News Releases
Epizyme Inc (EPZM) Q4 2020 Earnings Call Transcript
Tags EPZM Market News
From Motley Fool
XBI's Underlying Holdings Could Mean 24% Gain Potential
Tags ETFs
From ETF Channel
Pharma Stock Ideas: Why BMO Is Recommending Regeneron, Constellation
Tags BMO Capital Markets Benzinga Upgrades
From Benzinga
Implied VHT Analyst Target Price: $244
Tags ETFs
From ETF Channel
EPZM Trading Below Director's Recent Buy Price
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.